Unknown

Dataset Information

0

The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28.


ABSTRACT: Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge domain (HD) and the transmembrane domain (TMD) between the extracellular antigen-targeting CARs and the intracellular signaling modalities of CARs has not been systemically studied. In this study, a series of 19-CARs differing only by their HD (CD8, CD28, or IgG4) and TMD (CD8 or CD28) was generated. CARs containing a CD28-TMD, but not a CD8-TMD, formed heterodimers with the endogenous CD28 in human T cells, as shown by co-immunoprecipitation and CAR-dependent proliferation of anti-CD28 stimulation. This dimerization was dependent on polar amino acids in the CD28-TMD and was more efficient with CARs containing CD28 or CD8 HD than IgG4-HD. The CD28-CAR heterodimers did not respond to CD80 and CD86 stimulation but had a significantly reduced CD28 cell-surface expression. These data unveiled a fundamental difference between CD28-TMD and CD8-TMD and indicated that CD28-TMD can modulate CAR T-cell activities by engaging endogenous partners.

SUBMITTER: Muller YD 

PROVIDER: S-EPMC8021955 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7864379 | biostudies-literature
| S-EPMC5839992 | biostudies-literature
| S-EPMC7477921 | biostudies-literature
| S-EPMC3083795 | biostudies-literature
| S-EPMC7378745 | biostudies-literature
| S-EPMC3863798 | biostudies-other
2018-08-19 | GSE109161 | GEO
| S-EPMC11365992 | biostudies-literature
| S-EPMC5865610 | biostudies-literature
| S-EPMC5536854 | biostudies-literature